SCHEMBL31708186

SCHEMBL31708186

C#C[C@@](C)(O)c1cnc(C)cn1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11970843 1.00 KMT2A (0.34) KMT2AATM
SCHEMBL18214842 0.77 KMT2A (0.35) KMT2AATM
SCHEMBL22715343 0.77 CYP19A1 (0.42) —
SCHEMBL22715928 0.77 CYP19A1 (0.42) —
SCHEMBL1572685 0.77 CYP19A1 (0.42) —
SCHEMBL7599416 0.72 VNN1 (0.31) —
SCHEMBL25207482 0.72 KMT2A (0.30) KMT2AATM
SCHEMBL19565979 0.71 GCKR (0.39) KMT2AATM
SCHEMBL3658981 0.70 — —
SCHEMBL11971234 0.70 MAP3K14 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143179-B1 AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER IDORSIA PHARMACEUTICALS LTD (CH) 2025-10-22 — — EP disclosed
Send feedback